RALPMH: Remote assessment of lung disease and impact on physical and mental health
- Conditions
- ung diseases (COPD, ILD, COVID19)Respiratory
- Registration Number
- ISRCTN16275601
- Lead Sponsor
- South London and Maudsley NHS Foundation Trust
- Brief Summary
2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34319235/ (added 29/07/2021) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37999935/ (added 14/05/2024) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38589216/ (added 16/05/2024)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
COPD cohort
1. Clinical Conditions: 20 patients with a diagnosis of COPD
2. Gender: M/F
3. Age range: 18+ years
4. Prior mobile phone use: required
5: Willingness to use monitoring devices and complete study questionnaires
6. History of exacerbation: 2 or more exacerbations in last 1 yr
ILD cohort
1. Clinical Conditions: 20 patients with a diagnosis of interstitial lung disease
2. Gender: M/F
3. Age range: 18-90
4. Prior mobile phone use: required
5: Willingness to use monitoring devices and complete study questionnaires
COVID-19 cohort
1. Clinical Conditions: a clinical diagnosis of COVID-19 (within 4-13 weeks of enrolment) who either and report symptoms interfering with day to day activity present for more than 28 days following the onset of COVID-19
2. Gender: M/F
3. Age range: 18+
4. Prior mobile phone use: required
5: Willingness to use monitoring devices and complete study questionnaires
Non-English language Speaker
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.